Rifampicin and stevens-johnson syndrome Patient Reports February 12, 2012
Rifampicin Side Effects Report #5090052-0
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 22, 2006. Male patient, 44 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Rifampicin dosage: unknown. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5091942-5
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 15, 2006. Male patient, 44 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome. Rifampicin dosage: unknown. During the same period patient was treated with ISONIAZID. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5092661-1
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 22, 2006. Male patient, 39 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Rifampicin dosage: unknown. Patient died.
Rifampicin Side Effects Report #5090051-9
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 22, 2006. Male patient, 35 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Rifampicin dosage: unknown. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5091970-X
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 15, 2006. Male patient, 35 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: dermatitis bullous, stevens-johnson syndrome. Rifampicin dosage: unknown. During the same period patient was treated with ISONIAZID. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5090050-7
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 22, 2006. Female patient, 29 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Rifampicin dosage: unknown. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5091948-6
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 15, 2006. Female patient, 24 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome. Rifampicin dosage: unknown. During the same period patient was treated with ISONIAZID. Patient was hospitalized. Patient died.
Rifampicin Side Effects Report #5092660-X
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 22, 2006. Female patient, 24 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Rifampicin dosage: unknown. Patient died.
Rifampicin Side Effects Report #5092659-3
Rifampicin side effect was reported by a Consumer or non-health professional from TOGO on Aug 22, 2006. Male patient, 20 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin. After drug was administered, patient experienced the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Rifampicin dosage: unknown. Patient died.
Rifampicin and stevens-johnson syndrome 